Editas Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	78.12	19.71	25.54	90.73	20.53	31.94	13.73	6.05	1.63	0
Revenue Growth (YoY)	296.32%	-22.83%	-71.85%	341.93%	-35.71%	132.64%	126.80%	271.58%	-	-
Gross Profit	78.12	19.71	25.54	90.73	20.53	31.94	13.73	6.05	1.63	0
Selling, General & Admin	69.65	70.7	76.18	67.58	64.56	55.01	50.5	46.26	18.1	7.65
Research & Development	177.65	174.96	142.51	158	96.9	90.65	83.16	56.98	18.85	5.07
Operating Expenses	247.3	245.66	218.69	225.57	161.45	145.66	133.66	103.24	36.94	12.72
Operating Income	-169.18	-225.95	-193.15	-134.84	-140.92	-113.73	-119.93	-97.19	-35.31	-12.72
Interest Expense / Income	-17.57	-5.52	-0.61	-2.61	-7.31	-3.45	0.98	-0.06	0.14	0.03
Other Expense / Income	1.6	-	-0.04	-16.26	0.14	-0.33	-0.59	0.06	37.45	0.93
Pretax Income	-153.22	-220.43	-192.5	-115.98	-133.75	-109.95	-120.32	-97.18	-72.9	-13.69
Net Income	-153.22	-220.43	-192.5	-115.98	-133.75	-109.95	-120.32	-97.18	-72.9	-13.69
Preferred Dividends	0	0	0	0	0	0	0	0.05	0.39	0.31
Net Income Common	-153.22	-220.43	-192.5	-115.98	-133.75	-109.95	-120.32	-97.23	-73.29	-13.99
Shares Outstanding (Basic)	76	69	68	59	50	47	40	32	3	1
Shares Outstanding (Diluted)	76	69	68	59	50	47	40	32	3	1
Shares Change	10.63%	1.55%	15.37%	17.26%	6.13%	16.80%	25.15%	1155.19%	128.56%	-
EPS (Basic)	-2.02	-3.21	-2.85	-1.98	-2.68	-2.33	-2.98	-3.02	-28.55	-12.46
EPS (Diluted)	-2.02	-3.21	-2.85	-1.98	-2.68	-2.33	-2.98	-3.02	-28.55	-12.46
Free Cash Flow	-136.9	-181.45	-171.78	-186.99	-46.73	-50.42	-11.46	-53.72	-6.87	-9.87
Free Cash Flow Per Share	-1.80	-2.64	-2.54	-3.19	-0.94	-1.07	-0.28	-1.67	-2.68	-8.79
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-216.56%	-1146.26%	-756.13%	-148.61%	-686.39%	-356.10%	-873.64%	-1605.62%	-2167.71%	-
Profit Margin	-196.13%	-1118.26%	-753.61%	-127.82%	-651.43%	-344.28%	-876.49%	-1606.31%	-4499.32%	-
Free Cash Flow Margin	-175.23%	-920.50%	-672.49%	-206.09%	-227.63%	-157.89%	-83.49%	-887.48%	-421.98%	-
EBITDA	-164.72	-219.61	-188.06	-114.62	-138.23	-110.15	-116.66	-96.04	-72.29	-13.49
EBITDA Margin	-210.85%	-1114.11%	-736.20%	-126.33%	-673.27%	-344.88%	-849.82%	-1586.70%	-4437.45%	-
Depreciation & Amortization	6.06	6.34	5.05	3.96	2.83	3.25	2.68	1.2	0.47	0.16
EBIT	-170.79	-225.95	-193.11	-118.58	-141.06	-113.4	-119.35	-97.25	-72.76	-13.65
EBIT Margin	-218.61%	-1146.26%	-755.99%	-130.69%	-687.05%	-355.07%	-869.36%	-1606.56%	-4466.36%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).